Literature DB >> 3571861

Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment.

K J Roghmann, P A Tabloski, D W Bentley, G Schiffman.   

Abstract

The immune response of 271 elderly persons to the new 23-valent pneumococcal vaccine was studied prospectively. Sera were obtained prevaccination, at 1 month post- and 12 months postvaccination. They were analyzed by radioimmunoassay for the presence of antibody Types 1, 3, 6A, 7F, 8, and 9N. The results showed differences in antibody levels by sex of the individual (p less than .01 pre and p = .04 at 1 month post), with women having lower antibody levels than men. Women responded better to vaccination than men (p = .05), but they also lost their acquired antibodies faster (p less than .01). No age effect and no effect of level of functioning were observed within this group of elderly individuals. Participants who died had high initial levels and responded well. Major differences between the six types were noticed. Type 6A exhibited the described pattern most clearly, whereas Type 3 often behaved in an opposite pattern from the other five types. We conclude that sex differences persist even among elderly adults, that high levels of antibodies are not necessarily an indicator of good health, and that much unexplained variation between antibody types exist.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571861     DOI: 10.1093/geronj/42.3.265

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  15 in total

Review 1.  Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Physiology (Bethesda)       Date:  2015-11

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

Review 3.  Immunosenescence revisited. Does it have any clinical significance?

Authors:  A J Voets; L R Tulner; G J Ligthart
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 4.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

5.  The immune response to pneumococcal polysaccharides 14 and 23F among elderly individuals consists predominantly of switched memory B cells.

Authors:  David J Leggat; Rebecca S Thompson; Noor M Khaskhely; Anita S Iyer; M A Julie Westerink
Journal:  J Infect Dis       Date:  2013-04-01       Impact factor: 5.226

6.  Immune responses of systemic and mucosal lymphoid organs to Pnu-Imune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant.

Authors:  M Garg; B Subbarao
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination.

Authors:  J B Rubins; M Alter; J Loch; E N Janoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice.

Authors:  M Garg; W Luo; A M Kaplan; S Bondada
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

9.  Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination.

Authors:  M A Julie Westerink; Harry W Schroeder; Moon H Nahm
Journal:  Aging Dis       Date:  2011-07-20       Impact factor: 6.745

Review 10.  Physiological changes due to age. Implications for respiratory drug therapy.

Authors:  J F Morris
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.